Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

Pharmacology Biochemistry and Behavior

Volumn 70, Issue 1, 2001, Pages 123-131

  Arévalo, Cristina ^a   De Miguel, Rosario ^b   Hernández Tristán, Rafael ^a  

^a Facultad de Biología   (Spain)

^b Facultad de Medicina   (Spain)

Author keywords

Anxiety; Cannabinoids; Dopamine; Exploratory behaviour; GABA; Holeboard; Hypothalamus; Motor activity; Plus maze; Rat; Serotonin

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; DOPAMINE; NEUROTRANSMITTER; RIMONABANT; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; EXPLORATORY BEHAVIOR; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MAZE TEST; MOTOR ACTIVITY; NEOPHOBIA; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ANALGESICS; ANIMALS; ANXIETY; CANNABINOIDS; CYCLOHEXANOLS; DRUG THERAPY, COMBINATION; EXPLORATORY BEHAVIOR; HYPOTHALAMUS; MALE; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0034866872     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00578-0     Document Type: Article

References (36)

1. 9-tetrahydrocannabinol: Studies on precipitated abrupt withdrawal
2. Behavioral responses to single and repeated restraint in male and female rats
3. 2 function
4. Behavioral effects of cannabinoid agents in animals
5. Ethopharmacological analysis of rat behavior on the elevated plus-maze
6. Effects of cannabinoids on prolactin an gonadotropin secretion: Involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputs
7. Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus
8. The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin and CRF-41
9. 2-Hydroxyestradiol is not mediating the effects of estradiol on tuberoinfundibular dopaminergic neurons controlling prolactin secretion in female rats
10. 9-tetrahydrocannabinol: Changes in hypothalamic biogenic amines and anterior pituitary secretion
11. Validity of head-dipping as a measure of exploration in a modified holeboard
12. The involvement of serotonin in regulation of pituitary-adrenocortical function
13. The cannabinoid agonist HU-210 modifies rat behavioural responses to novelty and stress
14. The regulation of hypothalamic corticotrophin-releasing factor release: In vitro studies
15. Adverse effects of Cannabis
16. 9-Tetrahydrocannabinol and the synthetic cannabinoid CP-55,940 induce expression of c-fos mRNA in stress responsive nuclei of rat brain
17. 9-THC on exploratory behaviour and memory in the rat
18. 9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes
19. Adrenalectomy reverses the effects of Delta-9-THC on mouse brain 5-hydroxytryptamine turnover
20. 9-tetrahydrocannabinol (THC): Involvement of serotoninergic and dopaminergic pathways
21. Effects of Delta-9-tetrahydrocannabinol; cannabinol and Cannabidiol alone and in combinations, on luteinizing hormone and prolactine release and on hypothalamic neurotransmitters in the male rat
22. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion
23. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors
24. 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity
25. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat
26. Pharmacological characterization of cannabinoids in the elevated plus-maze
27. Validation of open:close entries in the elevated plus-maze as a measure of anxiety in the rat
28. SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor
29. 9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas
30. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal
31. Corticotropin-releasing factor (CRF) antagonist [D-PHE12, Nle,21,38, CaMeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive withdrawal behaviour in rats
32. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis
33. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat
34. Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection
35. Effect of chronic pretreatment with the sigma ligand JO 1784 on CRF-induced changes in behaviour, neurotransmitter and immunological function in the rat
36. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716